MA52257A
(en )
2021-04-21
PHARMACEUTICAL COMPOSITIONS CONSISTING OF BLAUTIA AND THEIR ORAL ADMINISTRATION
MA50541A
(en )
2021-04-07
PHARMACEUTICAL FORMULATIONS
DK3099356T3
(en )
2020-05-18
DRUG ADMINISTRATION DEVICE
MA42303A
(en )
2018-05-09
PHARMACEUTICAL FORMULATIONS
HK1223935A1
(en )
2017-08-11
Amorphous letermovir and solid pharmaceutical formulations thereof for oral administration
ZA201903101B
(en )
2020-11-25
Pharmaceutical formulations
DK3236935T3
(en )
2024-10-21
PHARMACEUTICAL DOSAGE FORM FOR USE ON MUCOUS MEMBRANES
DK3709978T3
(en )
2023-06-12
Pharmaceutical oral formulation comprising bacteria
ZA201703562B
(en )
2018-11-28
Pharmaceutical composition for oral administration comprising taxane
BR112017013012A2
(en )
2018-06-26
indenyl compounds, pharmaceutical compositions and medical uses thereof
IL262204A
(en )
2018-11-29
Granule formulation for oral administration
HK1248544A1
(en )
2018-10-19
Stable pharmaceutical composition for oral administration
PL3157506T3
(en )
2021-03-08
Taste-masked oral pharmaceutical composition
DK3280447T3
(en )
2019-05-13
PHARMACEUTICAL FORMULATIONS
HK1245646A1
(en )
2018-08-31
Pharmaceutical composition for oral administration
DK3107568T3
(en )
2024-06-03
Formulations for administration to the small intestine
GB201417589D0
(en )
2014-11-19
Pharmaceutical Formulations
HK1232144A1
(en )
2018-01-05
Pharmaceutical composition for oral administration
DK2952207T3
(en )
2019-06-24
OIL-BASED PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION
TH1501007612A
(en )
2017-07-27
Amorphous letermovir and its pharmaceutical solid formulations for oral administration.
EP3512507A4
(en )
2019-11-13
Oral medication formulations
BR112017004882A2
(en )
2018-11-06
oral pharmaceutical composition.
PL3373945T3
(en )
2021-03-08
An oral drug formulation comprising silybin
GB201610440D0
(en )
2016-07-27
Pharmaceutical formulations
TH1601003393A
(en )
2017-09-21
Pharmaceutical dosage form